New developments in transplant-acquired allergies
Open Access
- 1 January 2013
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Transplantation
- Vol. 3 (3), 30-5
- https://doi.org/10.5500/wjt.v3.i3.30
Abstract
Transplant-acquired allergy (TAA) was firstly described as transplant-acquired food allergy (TAFA) after bone marrow transplantations and mostly observed in a transient form. The picture is complicated by numerous case reports of TAFA after the receipt of liver grafts from donors with no documented history of food allergy. The estimated prevalence of TAFA among young children in the literature has been documented in various studies ranging from 6% to 57%. Although TAA is mostly found to be associated with liver transplantation; it has been recently reported to be related with heart, intestinal, lung and even renal transplantations in adults. Previous reviews of published cases of liver TAA misleadingly emphasized the predominance of children and the absence of TAA in cardiac, pulmonary, and renal transplant recipients. In different studies, the male/female ratio is equal. Literature data suggest that children with TAFA typically present within the first year after surgery and are typically allergic to multiple foods. The pathogenesis of TAA is not still completely understood. Most of the studies support the concept that the functioning liver itself, and not only tacrolimus immunosuppression, is one of the main contributors to TAA in these patients. In the light of recent findings, other possible mechanisms can be summarized as following: (1) the recovery of delayed type hypersensitivity; (2) late manifestation of food allergy; (3) intestinal injury as well as inhibition of cellular energy production by tacrolimus; and (4) transfer of food-specific IgE or lymphocytes. Thus, interplay between hematopoietic cells from the transplanted organ and recipient specific factors (e.g., younger age and atopic background) seem to underlie the development of TAA. Most patients will have symptomatic improvement following reduced immunosuppression and an appropriately restricted diet. Nevertheless, some studies suggest that atopic diseases occur in some of pediatric liver transplant recipients, with manifestations including food allergy, eczema, allergic rhinitis, and asthma. More studies would be needed including greater number of patients to determine whether TAA is transient or not in pediatric/adult solid organ recipients.Keywords
This publication has 33 references indexed in Scilit:
- Long‐term follow‐up of de novo allergy in pediatric liver transplantation – 10 yr experience of a single centerPediatric Transplantation, 2013
- Presentation of atopic disease in a large cohort of pediatric liver transplant recipientsPediatric Transplantation, 2012
- Allergic sensitization in kidney-transplanted patients prevails under tacrolimus treatmentClinical & Experimental Allergy, 2011
- Immunosuppressive Therapy Does Not Prevent the Occurrence of Immunoglobulin E–Mediated Allergies in Children and Adolescents With Organ TransplantsPEDIATRICS, 2006
- Tacrolimus‐associated eosinophilic gastroenterocolitis in pediatric liver transplant recipients: Role of potential food allergies in pathogenesisPediatric Transplantation, 2006
- Manifestation of Atopic Eczema in Children after Heart Transplantation in the First Year of LifePediatric Dermatology, 2005
- Allergic disease after pediatric liver transplantation with systemic tacrolimus and cyclosporine a therapyTransplantation Proceedings, 2003
- Transfer of Symptomatic Peanut Allergy to the Recipient of a Combined Liver-And-Kidney TransplantThe New England Journal of Medicine, 1997
- Life-Threatening Food Allergy in a Child Treated with FK506Journal of Pediatric Gastroenterology and Nutrition, 1997
- Recovery of delayed-type hypersensitivity following liver transplantation.1995